Thrivent Financial for Lutherans’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.92M | Sell |
|
|||||
|
2025
Q2 | $1.96M | Buy |
|
|||||
|
2025
Q1 | $1.5M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.27M | Sell |
|
|||||
|
2024
Q1 | $1.51M | Buy |
|
|||||
|
2023
Q4 | $1.81M | Buy |
|
|||||
|
2023
Q3 | $228K | Sell |
|
|||||
|
2023
Q2 | $4.95M | Sell |
|
|||||
|
2023
Q1 | $5.02M | Buy |
|
|||||
|
2022
Q4 | $1.31M | Sell |
|
|||||
|
2022
Q3 | $2.77M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $8.13M | Sell |
|
|||||
|
2021
Q3 | $11.8M | Sell |
|
|||||
|
2021
Q2 | $17.6M | Sell |
|
|||||
|
2021
Q1 | $22.9M | Buy |
|
|||||
|
2020
Q4 | $42.2M | Buy |
|
|||||
|
2020
Q3 | $32M | Buy |
|